Company / Total Assets
NRX Pharmaceuticals, Inc. Total Assets History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$13.0M
FY2025
5-year range
$3.7M / $13.0M
FY2024-FY2025
Trend
+254.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$13M in FY2025.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, total assets increased 254.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -5.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.0M | +254.9% |
| FY2024 | $3.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026